THE VALUE OF SYSTEMIC INFLAMMATORY BIOMARKERS IN ASSESSING SEVERITY IN PATIENTS WITH CEREBRAL INFARCTION. YHCĐ. 2026;67(CĐ11-NCKH). doi:10.52163/yhc.v67iCD11.6035